Form 8-K - Current report:
SEC Accession No. 0001641172-25-015571
Filing Date
2025-06-18
Accepted
2025-06-18 16:01:54
Documents
13
Period of Report
2025-06-17
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 37689
2 EX-3.1 ex3-1.htm EX-3.1 5830
  Complete submission text file 0001641172-25-015571.txt   210938

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cocp-20250617.xsd EX-101.SCH 3035
4 XBRL LABEL FILE cocp-20250617_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE cocp-20250617_pre.xml EX-101.PRE 22372
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3703
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38418 | Film No.: 251056786
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)